DEA Proposes New Import, Export Restrictions for Amineptine

The Drug Enforcement Administration is proposing to list amineptine, a synthetic tricyclic antidepressant with central nervous system (CNS) stimulating properties that, according to the Department of Health and Human Services, has no approved medical use and no known therapeutic application in the U.S., under schedule I of the Controlled Substances Act, it said in a notice released July 21. "If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle, amineptine." Comments are due Sept. 20.